High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
2.17B
-11.9%
2.647
-18.56%
1.87B
-13.6%
1.984
-24.58%
2.37B
-5.95%
3.325
+3.27%
Estimates Revision
The market is revising Downward the revenue expectations for Constellation Brands, Inc. (STZ) for FY2026, with the revenue forecasts being adjusted by -1.56% over the past three months. During the same period, the stock price has changed by -5.38%.
Revenue Estimates for FY2026
Revise Downward
-1.56%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
-1.93%
In Past 3 Month
Stock Price
Go Down
-5.38%
In Past 3 Month
21 Analyst Rating
Wall Street analysts forecast STZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STZ is 167.40 USD with a low forecast of 123.00 USD and a high forecast of 215.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
8 Hold
2 Sell
Moderate Buy
Current: 138.030
Low
123.00
Averages
167.40
High
215.00
Current: 138.030
Low
123.00
Averages
167.40
High
215.00
Piper Sandler
Michael Lavery
Neutral
downgrade
$155 -> $135
2025-11-21
Reason
Piper Sandler
Michael Lavery
Price Target
$155 -> $135
2025-11-21
downgrade
Neutral
Reason
Piper Sandler analyst Michael Lavery lowered the firm's price target on Constellation Brands (STZ) to $135 from $155 and keeps a Neutral rating on the shares. The firm says it is updating its models and price targets for recently announced GLP-1 news, higher ABV headwinds, as well as tariff relief and other company specific updates. President Trump recently announced deals with Eli Lilly (LLY) and Novo Nordisk (NVO) to cut GLP-1 drug prices for Medicare and Medicaid beneficiaries in 2026 and offer the treatments directly to consumers at a discount on TrumpRX. Faster user uptake growth in the US appears directionally clear, and Piper now estimates about 20% of the U.S. population could be users by 2028.
Citi
Neutral
downgrade
$155 -> $145
2025-09-23
Reason
Citi
Price Target
$155 -> $145
2025-09-23
downgrade
Neutral
Reason
Citi lowered the firm's price target on Constellation Brands to $145 from $155 and keeps a Neutral rating on the shares ahead of the fiscal Q4 report on October 6. The firm cites scanner data weakness and potential margin risk for the target cut.
Barclays
Overweight -> Equal Weight
downgrade
$202 -> $150
2025-09-12
Reason
Barclays
Price Target
$202 -> $150
2025-09-12
downgrade
Overweight -> Equal Weight
Reason
Barclays downgraded Constellation Brands to Equal Weight from Overweight with a price target of $150, down from $202. The firm believes beer category trends and investor sentiment "are likely to be weighed down for some time." The firm is challenged to find a near-term catalyst for beer trends and downgraded Constellation as a result.
Citi
Filippo Falorni
Neutral
downgrade
$174 -> $155
2025-09-04
Reason
Citi
Filippo Falorni
Price Target
$174 -> $155
2025-09-04
downgrade
Neutral
Reason
Citi analyst Filippo Falorni lowered the firm's price target on Constellation Brands to $155 from $174 and keeps a Neutral rating on the shares. The company's fiscal 2026 guidance cut came in worse than expected, the analyst tells investors in a research note.
Bernstein
Bernstein
Outperform
maintain
$225 -> $195
2025-09-04
Reason
Bernstein
Bernstein
Price Target
$225 -> $195
2025-09-04
maintain
Outperform
Reason
Bernstein lowered the firm's price target on Constellation Brands to $195 from $225 and keeps an Outperform rating on the shares. The firm notes that earlier this week, Constellation meaningfully cut its 2026 guidance. Lower guided corporate expense and net interest expense are offset by lower equity in earnings and a higher comparable tax rate, bringing the cut to EPS guidance to about 10%.
TD Cowen
Hold
downgrade
$180 -> $152
2025-09-04
Reason
TD Cowen
Price Target
$180 -> $152
2025-09-04
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Constellation Brands to $152 from $180 and keeps a Hold rating on the shares. The firm noted they lowered their FY26 organic growth outlook to -6% to -4% from -2% to +1% due to weak beer sales. The guidance reduction exceeded expectations and reinforced the cautious view the firm expressed earlier about velocity declines in beer offsetting the benefits of expanding distribution.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Constellation Brands Inc (STZ.N) is 11.63, compared to its 5-year average forward P/E of 18.91. For a more detailed relative valuation and DCF analysis to assess Constellation Brands Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Strongly Undervalued
5Y Average PE
18.91
Current PE
11.63
Overvalued PE
22.25
Undervalued PE
15.57
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
14.68
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
16.63
Undervalued EV/EBITDA
12.72
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
4.31
Current PS
0.00
Overvalued PS
4.98
Undervalued PS
3.64
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
STZ News & Events
Events Timeline
(ET)
2025-10-07
09:55:01
Significant Early Gainers in Liquid Options on October 7th
2025-10-07
08:59:54
Video: IBM and IntercontinentalExchange Gain Momentum from Partnerships with Promising Start-ups
2025-10-06 (ET)
2025-10-06
16:13:27
Constellation Brands supports FY26 EPS forecast of $11.30-$11.60, with consensus at $11.44.
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/20251205062043_49d67c27d2e2c112a23ae33f54125899.jpeg)
Preview
9.5
06:20 AMGlobenewswirePinnedConstellation Brands to Report Q3 Financial Results on January 7, 2026
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/c4b07eb0f6dcbc756518770ba537b5f8ff071d774018be74a88b17f411439128.png)
Preview
3.0
12-02Barron'sThe 12 Poorest Performing Stocks of 2025—and the One That Might Make a Comeback
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/62213a45bb4bb6c2445c93dcc47cede8a72232acd4d50496f3ed2c33d06e18ae.jpg)
Preview
8.0
11-27NASDAQ.COMSignificant Options Activity on Wednesday: STZ, OXY, KGS
Sign Up For More News
People Also Watch
FAQ
What is Constellation Brands Inc (STZ) stock price today?
What is Constellation Brands Inc (STZ)'s business?
What is the price predicton of STZ Stock?
What is Constellation Brands Inc (STZ)'s revenue for the last quarter?
What is Constellation Brands Inc (STZ)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Constellation Brands Inc (STZ)'s fundamentals?
How many employees does Constellation Brands Inc (STZ). have?